Dynavax Technologies Corporation (DVAX) Financial Statements (2023 and earlier)

Company Profile

Business Address 2100 POWELL STREET
EMERYVILLE, CA 94608
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:624,395546,000165,000151,100145,500191,900
Cash and cash equivalents202,004436,18932,07339,88449,34826,584
Short-term investments422,391109,761132,963111,17196,188165,270
Other undisclosed cash, cash equivalents, and short-term investments  50(36)45(36)46
Receivables      
Inventory, net of allowances, customer advances and progress billings59,44661,33563,68941,33219,022312
Inventory59,44661,33563,68941,33219,022312
Intangible current assets      1,306
Other undisclosed current assets233,144365,18561,32616,2219,8424,505
Total current assets:916,985972,520290,015208,653174,364198,023
Noncurrent Assets
Operating lease, right-of-use asset25,74525,96426,58330,252
Property, plant and equipment37,59635,02030,56732,02217,06416,619
Intangible assets, net (including goodwill)2,0062,1252,2974,58113,8612,244
Goodwill2,0062,1252,2972,0812,1442,244
Intangible assets, net (excluding goodwill)    2,50011,717 
Restricted cash and investments207219237216619629
Other noncurrent assets3,3113,3983,5733,3444,9761,270
Total noncurrent assets:68,86566,72663,25770,41536,52020,762
TOTAL ASSETS:985,8501,039,246353,272279,068210,884218,785
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities33,93065,40731,09530,73329,37714,234
Employee-related liabilities13,0118,6846,6538,058 
Accounts payable3,2112,6003,3129,2785,2784,539
Accrued liabilities30,71949,79619,09914,80216,0419,695
Deferred revenue  55,400  
Debt    3,039  
Restructuring reserve    675  
Other liabilities3,6312,5903,2479,9877,000 
Other undisclosed current liabilities112,513433,00543,0698,6131,6564,359
Total current liabilities:150,074556,40277,41153,04738,03318,593
Noncurrent Liabilities
Long-term debt and lease obligation  34,316214,600216,446100,871 
Long-term debt, excluding current maturities   179,811178,601100,871 
Liabilities, other than long-term debt33,1855,6642,5681,2858,915643
Other liabilities3845,6642,5681,2858,915643
Operating lease, liability32,80134,31634,78937,845
Other undisclosed noncurrent liabilities221,578220,490    
Total noncurrent liabilities:254,763260,470217,168217,731109,786643
Total liabilities:404,837816,872294,579270,778147,81919,236
Equity
Equity, attributable to parent581,013222,37458,6938,29063,065199,549
Common stock128123110846362
Additional paid in capital1,510,5181,441,8681,352,3741,229,4171,131,2411,107,693
Accumulated other comprehensive income (loss)(5,438)(2,266)273(2,387)(2,015)(881)
Accumulated deficit(924,195)(1,217,351)(1,294,064)(1,218,824)(1,066,224)(907,325)
Total equity:581,013222,37458,6938,29063,065199,549
TOTAL LIABILITIES AND EQUITY:985,8501,039,246353,272279,068210,884218,785

Income Statement (P&L) ($ in thousands)

6/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues722,683439,44246,55135,2198,198327
Revenue, net327
Sublease income  7,7062,619
Cost of revenue(262,153)(173,572)(2,786)(10,433)(10,862) 
Cost of goods and services sold(262,153)(173,572)(2,500)(9,217)(10,862) 
Gross profit:460,530265,87043,76524,786(2,664)327
Operating expenses(178,008)(132,384)(112,136)(159,629)(161,517)(96,332)
Other undisclosed operating income 1,0001,000  10,862 
Operating income (loss):283,522134,486(68,371)(134,843)(153,319)(96,005)
Nonoperating income8,0231,0623634,1013,758851
Investment income, nonoperating7,9121401,2603,3703,8281,337
Other nonoperating income (expense)111922(897)731(70)(486)
Interest and debt expense(6,732)(16,408)(19,062)(16,977)(9,338) 
Other undisclosed loss from continuing operations before equity method investments, income taxes    (4,881)  
Income (loss) from continuing operations before equity method investments, income taxes:284,813119,140(87,070)(152,600)(158,899)(95,154)
Other undisclosed income (loss) from continuing operations before income taxes9,486(41,619)    
Income (loss) from continuing operations before income taxes:294,29977,521(87,070)(152,600)(158,899)(95,154)
Income tax expense(1,143)(808)    
Income (loss) from continuing operations:293,15676,713(87,070)(152,600)(158,899)(95,154)
Income (loss) before gain (loss) on sale of properties:76,713(87,070)(152,600)(158,899)(95,154)
Net income (loss):293,15676,713(87,070)(152,600)(158,899)(95,154)
Other undisclosed net income attributable to parent   11,830   
Net income (loss) attributable to parent:293,15676,713(75,240)(152,600)(158,899)(95,154)
Preferred stock dividends and other adjustments    (3,267)  
Undistributed earnings (loss) allocated to participating securities, basic2834,569    
Other undisclosed net income (loss) available to common stockholders, basic(566)(9,138)    
Net income (loss) available to common stockholders, basic:292,87372,144(75,240)(155,867)(158,899)(95,154)
Other undisclosed net income (loss) available to common stockholders, diluted3,5263,547(4,124)   
Net income (loss) available to common stockholders, diluted:296,39975,691(79,364)(155,867)(158,899)(95,154)

Comprehensive Income ($ in thousands)

6/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income (loss):293,15676,713(87,070)(152,600)(158,899)(95,154)
Other comprehensive income (loss)(3,172)(2,539)2,660(372)(1,134)2,743
Comprehensive income (loss):289,98474,174(84,410)(152,972)(160,033)(92,411)
Other undisclosed comprehensive income, net of tax, attributable to parent   11,830   
Comprehensive income (loss), net of tax, attributable to parent:289,98474,174(72,580)(152,972)(160,033)(92,411)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: